Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0002-1824-2337Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Haopeng Yang, Kotaro Arita, Kevin Bowman…·Michael R. Green
The paper establishes a PDX repository of large B-cell lymphoma models capturing clinical and molecular diversity, including post-CART19 progression cases.
Neeraj Y. Saini, David M. Swoboda, Uri Greenbaum…·Koichi Takahashi
This study finds that clonal hematopoiesis mutations, particularly in DNMT3A, TET2, and ASXL1, are linked to increased toxicity in patients undergoing anti-CD19 CAR T-cell therapy for large B-cell lymphoma.
Man Chun John Ma, Saber Tadros, Alyssa C. Bouska…·Michael R. Green
This study identifies subtype-specific and co-occurring genetic alterations across major B-NHL subtypes using targeted sequencing of 380 genes in 685 tumors.
Neeraj Kumar Jain, Keenan T. Hartert, Saber Tadros…·Michael R. Green
The paper identifies TCF4 overexpression driven by 18q21.2 gains as a mechanism promoting IgM expression in ABC-like DLBCL and shows BET inhibitors can suppress it.